Meeting of Global Advisory   Committee on Vaccine Safety,   18-19 June 2008.
D000328:Adult; D001249:Asthma / Q000209:etiology; D002648:Child; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects / Q000592:standards; D005260:Female; D006801:Humans; D028361:Mitochondrial Diseases / Q000209:etiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects; D012411:Rubella Vaccine / Q000009:adverse effects; D013849:Thimerosal / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects / Q000592:standards*; D014944:World Health Organization / Q000458:organization & administration; D022341:Yellow Fever Vaccine / Q000592:standards
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D011310:Preservatives, Pharmaceutical; D012411:Rubella Vaccine; D014612:Vaccines; D022341:Yellow Fever Vaccine; D013849:Thimerosal